Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease
- PMID: 3038438
- PMCID: PMC1542599
Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease
Abstract
Modification of beta-2-microglobulin has been shown to occur in vitro in serum of patients suffering of small cell lung cancer, where it clearly correlated to the clinical course of disease. The cause of serum beta-2-microglobulin modification occurring in these patients is investigated in the present study. This revealed that modification of beta-2-microglobulin is due to cleavage by a serine protease, which is dependent on divalent cations and has a trypsin-like specificity. The process showed the following characteristics: pH optimum at 8.5, heat inactivation by incubation at 56 degrees C for 20 min and temperature optimum at 20 degrees C.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials